← Leaderboards
Yejin Kim
University Of Texas Hlth Sci Ctr Houston
$1,601,315
Attributed
$3,202,629
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,202,629 · 3
By mechanism
R01$3,202,629 · 3
Top collaborators
- Xiaoqian Jiang5 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Yong Chen$12,599,201
- Janelle Rios$5,577,129
- Pramod K Dash$24,504,172
- Nancy I. Bergstrom$2,562,519
- Arif Ozgun Harmanci$1,674,201
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposPatient SubsetsInnovationMachine Learning ModelS DiseasePatient PopulationEnsureLearningData SetPharmaceutical PreparationsRandomized, Clinical TrialsIndividual ResponseCharacteristicsClinical TrialsTreatment EffectDrug DevelopmentS Disease PatientFutureTherapy DevelopmentImpaired CognitionTreatment ResponseRecommendationOutcome PredictionHeterogeneity
Grant awards (5)
Data-driven Subtypes of Alzheimer's disease progression for targeted treatment$762,929
R01 · FY2025 · AG · contact PI
Data-driven Subtypes of Alzheimer's disease progression for targeted treatment$778,499
R01 · FY2024 · AG · contact PI
Harmonizing multiple clinical trials for Alzheimer's disease to investigate differential responses to treatment via federated counterfactual learning$679,268
R01 · FY2024 · AG · contact PI
Harmonizing multiple clinical trials for Alzheimer's disease to investigate differential responses to treatment via federated counterfactual learning$679,268
R01 · FY2023 · AG · contact PI
Finding combinatorial drug repositioning therapy for Alzheimer's disease and related dementias$302,665
R01 · FY2022 · AG